Evolus (EOLS) Income towards Parent Company (2017 - 2026)

Evolus (EOLS) reported Income towards Parent Company of -$10.7 million for Q1 2026, up 43.5% on a YoY basis from -$7.4 million in Q1 2025, and down 8310.77% quarter-over-quarter from $130000.0 in Q4 2025.

Evolus (EOLS) Income towards Parent Company (2017 - 2026) Analysis & Trends

Evolus has reported Income towards Parent Company for 10 years, with the latest figure at -$10.7 million in Q1 2026.

  • For the quarter ending Q1 2026, Income towards Parent Company rose 43.5% year-over-year to -$10.7 million; the trailing twelve-month figure through Mar 2026 stood at -$43.4 million (up 22.74% YoY), and the FY2025 full-year result was -$51.6 million, down 2.42% from the prior year.
  • Income towards Parent Company for Q1 2026 stood at -$10.7 million, down from $130000.0 in the prior quarter.
  • The five-year high for Income towards Parent Company was $130000.0 in Q4 2025, with the low at -$23.5 million in Q2 2022.
  • Historically, Income towards Parent Company has averaged -$14.6 million across 5 years, with a median of -$15.7 million in 2025.
  • Annual changes were most pronounced in 2022 — Income towards Parent Company plunged 373.41% — and 2025, when it soared 101.91%.
  • Evolus' Income towards Parent Company stood at -$13.2 million in 2022, then rose by 10.13% to -$11.8 million in 2023, then jumped by 42.6% to -$6.8 million in 2024, then surged by 101.91% to $130000.0 in 2025, then slumped by 8310.77% to -$10.7 million in 2026.
  • The last three Income towards Parent Company figures came in at -$10.7 million (Q1 2026), $130000.0 (Q4 2025), and -$15.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 38.77 Bn 35.04 Bn 1.97 Bn
2 Zoetis 34.11 Bn 32.16 Bn 1.62 Bn
3 United Therapeutics 23.68 Bn 21.53 Bn 648.10 Mn
4 Aurora Cannabis 16.48 Bn 16.40 Bn 33.43 Mn
5 Neurocrine Biosciences 16.19 Bn 14.88 Bn 800.70 Mn
6 Elanco Animal Health 11.44 Bn 11.01 Bn 785.00 Mn
7 Alkermes 7.28 Bn 6.77 Bn -116.06 Mn
8 Lantheus Holdings 6.48 Bn 5.98 Bn 230.92 Mn
9 Hims & Hers Health 6.35 Bn 5.60 Bn 396.79 Mn
10 Evolus 439.03 Mn 389.24 Mn 48.90 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -10.67 Mn
Dec 31, 2025 130,000.00
Sep 30, 2025 -15.74 Mn
Jun 30, 2025 -17.14 Mn
Mar 31, 2025 -18.89 Mn
Dec 31, 2024 -6.79 Mn
Sep 30, 2024 -19.17 Mn
Jun 30, 2024 -11.35 Mn
Mar 31, 2024 -13.11 Mn
Dec 31, 2023 -11.83 Mn
Sep 30, 2023 -16.92 Mn
Jun 30, 2023 -18.14 Mn
Mar 31, 2023 -14.79 Mn
Dec 31, 2022 -13.16 Mn
Sep 30, 2022 -20.28 Mn
Jun 30, 2022 -23.47 Mn
Mar 31, 2022 -17.50 Mn
Dec 31, 2021 -18.18 Mn
Sep 30, 2021 -19.43 Mn
Jun 30, 2021 -15.60 Mn